抗球虫药物市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

抗球虫药市场按药物类型(离子载体抗球虫药和化学衍生物抗球虫药)、动物和地理细分

市场快照

anticoccidial market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

抗球虫药物市场的推动因素包括食用动物和伴侣动物球虫病发病率上升,以及全球对动物健康意识的提高。

此外,兽医保健的进步是推动全球研究市场增长的主要因素之一。例如,2019 年 4 月,Creative Diagnostics 宣布为其全球客户推出一系列创新的抗球虫药物分析产品和服务。

然而,使用疫苗和草药等替代疗法来治疗球虫病可能会阻碍全球抗球虫药物市场的增长。

报告范围

球虫病是家养动物中最常见和流行的寄生虫病之一,其症状包括体重减轻、轻度间歇性至重度腹泻、粪便中含有粘液或血液、脱水和繁殖减少。球虫病是由称为艾美球虫的单细胞寄生虫(原生动物)引起的,它在肠道中经历一个简单的生命周期。任何用于对抗鸟类或动物球虫病进展的药物,无论是食品生产还是非食品生产,都被称为抗球虫药。

By Drug Type
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
By Animal
Poultry
Swine
Fish
Cattle
Companion Animals
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

离子载体抗球虫部门主导抗球虫药物市场

  • 1972 年,随着第一个聚醚离子载体抗球虫药莫能菌素的推出,通过饲料药物预防球虫病取得了重大突破。这种类型的抗球虫剂通常被称为离子载体,这个术语来源于它们的一般化学结构。离子载体是链霉菌和其他真菌种类的发酵产物。
  • 此外,这些药物被广泛用于预防球虫病,因为它们对大多数球虫病原菌具有广谱活性,并且缺乏耐药性。每种都有不同的作用方式,并且没有产生明显的阻力。这些药物通常添加到起始饲料和生长饲料中,而不是添加到育肥饲料或停药饲料中。
  • 此外,当将相同的离子载体抗球虫剂添加到发酵剂和生长剂饲料中时,它被称为直接程序。2017 年,美国食品和药物管理局报告称,国内销售和分销的非医学重要抗菌药物的 82% 来自离子载体,总计 4,394,850 公斤。
  • 由于上述因素,预计离子载体抗球虫细分市场将在预测期内实现健康增长。
anticoccodial.png

北美是抗球虫药物市场增长最快的地区

北美是全球抗球虫药物的主要市场。目前,北美抗球虫药市场正在显着增长。这可归因于多种抗球虫药物的可用性,包括化学品和聚醚离子载体,以及在动物饲料中预防性使用抗球虫药物。此外,诸如预防球虫病意识的提高、安全的动物食品供应以及主要用于开发新产品的高额研发投资等因素,可能会在预测期内推动北美抗球虫药市场的增长。

Anticoccidial Drugs Market - Growth Rate by Region - Image

竞争格局

抗球虫药市场竞争激烈。主要市场参与者主要专注于持续的产品开发,同时采用增长战略,例如合并、收购以及与其他市场参与者的合作。主要参与者包括拜耳动物保健、勃林格殷格翰、Ceva 动物保健公司、Elanco 动物保健、默克、梅里亚、维克和硕腾动物保健等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Coccidiosis, Globally

      2. 4.2.2 Advancements in Veterinary Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatment Options in the Market

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Drug Type

      1. 5.1.1 Ionophore Anticoccidials

      2. 5.1.2 Chemical Derivative Anticoccidials

    2. 5.2 By Animal

      1. 5.2.1 Poultry

      2. 5.2.2 Swine

      3. 5.2.3 Fish

      4. 5.2.4 Cattle

      5. 5.2.5 Companion Animals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Animal Healthcare

      2. 6.1.2 Phibro Animal Health Corporation

      3. 6.1.3 Huvepharma

      4. 6.1.4 Elanco

      5. 6.1.5 Bayer AG

      6. 6.1.6 Ceva Animal Health Inc.

      7. 6.1.7 Impextraco NV

      8. 6.1.8 Virbac

      9. 6.1.9 Boehringer Ingelheim International GmbH

      10. 6.1.10 MSD Animal Health

      11. 6.1.11 Vetoquinol SA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anticoccidial Drugs Market market is studied from 2018 - 2026.

The Anticoccidial Drugs Market is growing at a CAGR of 4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation, Huvepharma, Virbac are the major companies operating in Anticoccidial Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!